citrulline has been researched along with Deep Vein Thrombosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ay, C; Brostjan, C; Däullary, T; Grilz, E; Hell, L; Martinod, K; Mauracher, LM; Pabinger, I; Posch, F; Thaler, J; Wagner, DD; Zielinski, C | 1 |
| Conesa-Zamora, P; Corral, J; Kristensen, SR; Martínez-Martínez, I; Miñano, A; Ordóñez, A; Pedersen, S; Stender, MT; Thorlacius-Ussing, O; Vicente, V; Yélamos, J | 1 |
2 other study(ies) available for citrulline and Deep Vein Thrombosis
| Article | Year |
|---|---|
Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.
Topics: Aged; Austria; Biomarkers; Blood Coagulation; Citrulline; Disease Progression; Extracellular Traps; Female; Fibrin Fibrinogen Degradation Products; Histones; Humans; Incidence; Male; Middle Aged; Neoplasm Staging; Neoplasms; Neutrophils; Nucleosomes; P-Selectin; Proportional Hazards Models; Prospective Studies; Remission Induction; Risk; Solubility; Venous Thromboembolism; Venous Thrombosis | 2018 |
Increased levels of citrullinated antithrombin in plasma of patients with rheumatoid arthritis and colorectal adenocarcinoma determined by a newly developed ELISA using a specific monoclonal antibody.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibody Specificity; Antithrombins; Arthritis, Rheumatoid; Biomarkers; Blood Coagulation; Citrulline; Colorectal Neoplasms; Enzyme-Linked Immunosorbent Assay; Factor Xa Inhibitors; Humans; Protein Processing, Post-Translational; Up-Regulation; Venous Thrombosis | 2010 |